PA
FULC icon

Profund Advisors’s Fulcrum Therapeutics FULC Stock Holding History

Profund Advisors’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Buy
32,514
+17,013
+110% +$103K ﹤0.01% 1138
2026
Q1 		$119K Buy
+15,501
New +$144K ﹤0.01% 1063
2024
Q4 		– Sell
-34,846
Closed -$124K – 1146
2024
Q3 		$124K Buy
34,846
+23,925
+219% +$177K ﹤0.01% 1095
2024
Q2 		$67.7K Buy
+10,921
New +$82.7K ﹤0.01% 1062

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Profund Advisors's FULC Position: Q2 2026 in Review

Profund Advisors increased its Fulcrum Therapeutics (FULC) stake by 110% in Q2 2026, buying an estimated $103K and bringing the position to 32,514 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #1138.

Profund Advisors first reported a position in FULC in Q2 2024 and has held it in 4 quarters since. The position peaked at $124K in Q3 2024. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Profund Advisors held 32,514 shares of Fulcrum Therapeutics worth $119K as of Q2 2026.
  • Profund Advisors bought 17,013 Fulcrum Therapeutics shares in Q2 2026, an estimated $103K.
  • Fulcrum Therapeutics made up ﹤0.01% of Profund Advisors's portfolio in Q2 2026, its #1138 holding.
  • Profund Advisors first reported a position in Fulcrum Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • Profund Advisors's Fulcrum Therapeutics position peaked at $124K in Q3 2024.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.